SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Dere Willard H

(Last) (First) (Middle)
ONE AMGEN CENTER DRIVE

(Street)
THOUSAND OAKS CA 91320-1799

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/13/2004
3. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr. V.P., Global Dev & CMO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 9,550 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
ISO (Right to Buy) 03/15/2005(1) 03/15/2011 Common Stock 3,362 59.48 D
ISO (Right to Buy) 07/07/2004(2) 07/07/2010 Common Stock 5,804 68.91 D
NQSO (Right to Buy) 03/15/2005(3) 03/15/2011 Common Stock 11,934 59.48 D
NQSO (Right to Buy) 07/07/2004(4) 07/07/2010 Common Stock 34,196 68.91 D
Explanation of Responses:
1. (WHD ISO 3/04) This option becomes exercisable in two equal installments of 1,681 shares each commencing 3/15/2008.
2. (WHD ISO 7/03) This option becomes exercisable in four equal installments of 1,451 shares each commencing 7/7/2004.
3. (WHD 3/04) This option becomes exercisable in three equal installments of 3,059 shares each and a final installment of 1,378 shares commencing 3/15/2005.
4. (WHD 7/03) This option becomes exercisable in four equal installments of 8,549 shares each commencing 7/7/2004.
/s/ William H. Dere 12/15/2004
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
rrd51508_58199.html
POWER OF ATTORNEY


                Know all men by these presents, that the undersigned hereby constitutes and
appoints each of Cris Prince, Ana G. Rodriguez, Ellen Gams and Mark A. Schlossberg signing
singly, the undersigned's true and lawful attorney-in-fact to execute for and on behalf of the
undersigned Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act
of 1934, as amended, and the rules thereunder, as may be required as a result of the
undersigned's position as an officer and/or director of Amgen Inc. (the "Company").


                The undersigned hereby grants to each such attorney-in-fact full power and
authority to execute such Forms 3, 4 and 5 as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-
in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934, as amended.


                This Power of Attorney shall remain in full force and effect until the undersigned
is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.


                IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 13th day of DECEMBER, 2004.


                                                        /s/ William H. Dere
                                                        Name:

1